FDA OKs J&J's Invokana for heart conditions

Singapore –  The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...

October 31, 2018 | Wednesday | News
Halozyme licenses $25M drug delivery technology to Roche

Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusi...

October 30, 2018 | Tuesday | News
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain

Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...

October 24, 2018 | Wednesday | News
FDA approves Regeneron, Sanofi's Dupixent for asthma treatment

Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...

October 22, 2018 | Monday | News
Roche's Tecentriq extends progression-free survival in TNBC

Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...

October 22, 2018 | Monday | News
Ostrich antibody as dengue fever solution ready for commercialization

Singapore - MAZ World and ZEAL Cosmetics have confirmed that Ostrich Antibodies are effective in neutralising all four s...

October 22, 2018 | Monday | News
Strides Pharma gets USFDA nod for its anti-epileptic drug

Strides Pharma Science (Strides) on Saturday announced that its global arm Strides Pharma Global Pte Singapore has recei...

October 22, 2018 | Monday | News
Eisai discovers new compound to treat Parkinson's disease

A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physi...

October 19, 2018 | Friday | News
Axsome receives FDA Orphan Drug designation for narcolepsy drug

Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the mana...

October 17, 2018 | Wednesday | News
FDA issues new guidance for developers of complex generics

 Singapore - The FDA has released new guidance documents aimed at advancing development of generic versio...

October 10, 2018 | Wednesday | News
Novartis’ crizanlizumab relieves patients from sickle cell pain crisis

Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal ...

October 10, 2018 | Wednesday | News
J&J abandons partnership for Geron’s cancer drug

Singapore - Johnson & Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat...

October 4, 2018 | Thursday | News
New drug blocks pancreatic cancer growth

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mi...

September 28, 2018 | Friday | News
Alexion to acquire Syntimmune

Alexion Pharmaceuticals and Syntimmune have entered into a definitive agreement for Alexion to acquire Syntimmune, a cli...

September 26, 2018 | Wednesday | News
Anaeropharma Science signs research agreement with Astellas

Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Ast...

September 25, 2018 | Tuesday | News
Accenture, Merck, Amazon partner to advance drug innovation and research

Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS),...

September 18, 2018 | Tuesday | News
Pfizer receives Breakthrough Therapy designation for inhibitor drug

Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthr...

September 6, 2018 | Thursday | News
China approves first "Made in China" cancer drug

China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...

September 6, 2018 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls